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Background
In omics studies many hundreds to tens of thousands of molecular variables are col-
lected for each individual, leading to high-dimensional multivariate data which are 
highly collinear. When analysing these data, many hypothesis tests are conducted 
simultaneously, thus effective methods to adjust for multiple testing are a central 
topic, especially in the context of Metabolome-Wide Association Studies (MWAS) 
[1]. The aim is the detection of statistically significant relationships between molec-
ular concentrations and disease outcomes while minimising the risk of false posi-
tive associations. A widely used approach for multiple testing is the false discovery 
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rate (FDR) [2] which controls the expected proportion of falsely rejected hypotheses 
among all those rejected. This approach is effective in the case of independent or pos-
itive dependent tests. While there have been some attempts to deal with correlated 
tests such as [3] that proposed a simple but highly conservative procedure, in general 
correlation among tests is still a problem for FDR methods. Besides FDR corrections, 
family-wise error rate (FWER) procedures control the probability of making at least 
one false conclusion (i.e. at least one Type I error). The FWER provides a more strin-
gent control of Type I error compared to the FDR. Nevertheless, conventional FWER 
methods such as the Bonferroni [4] or Sidak [5] adjustment are known to be overly 
conservative when the tests are correlated. On the other hand, resampling-based 
methods such as the permutation test are a standard tool to simultaneously assess the 
association of different correlated molecular quantities with an outcome of interest. 
These procedures can be conducted in both a parametric or non-parametric fashion. 
Parametric approaches are the preferred methods as they have relatively high power 
if the assumptions (e.g. normality of the data) hold. Nevertheless, in the context of 
MWAS the metabolic profiles are very rarely normally distributed nor present a sym-
metric distribution, and this may bias the result of the chosen significance test.
Thus, a first aim of this study is to overcome this issue and derive a valid yet sta-
ble metabolome-wide significance level (MWSL) across outcomes with diverse dis-
tributional properties. The proposed approach is based on a permutation procedure 
built from parametric approximation methods via the multivariate Normal and log-
Normal distributions to describe the set of metabolic profiles while retaining their 
complex correlated structure up to the 2nd order moments, while effectively control-
ling the expected overall type I error rate at the α level. While the proposed re-sam-
pling-based method is accurate and asymptotically consistent it demands intensive 
computation. In the context of genomic studies there have been several attempts to 
formulate the problem in terms of estimating the number of non-redundant molecu-
lar quantities as a closed-form eigenvalue-based measure from the spectral decom-
position of the empirical correlation matrix of the molecular variables. The available 
measures proposed by [6–9], and [10] are found not to be sufficiently accurate as a 
valid substitute for the proposed permutation procedure. Therefore, a second aim 
of this study is to derive a permutation-free closed-form estimate of the MWSL to 
express the number of non-redundant molecular quantities. Both the permutation-
based MWSL formulation and the more practical closed form expression are tested 




Suppose the data consists of n observations, and let Y be the outcome of interest, 
X = (X1, . . . ,XM)T  the vector of M predictors or features, and Z = (Z1, . . . ,ZP)T  the 
vector of P fixed effect covariates. The permutation-based MWSL estimation can be 
described as follows.
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• Step (1): Shuffle i.e. re-sample without replacement, the outcome variable Y together 
with the set of fixed effects confounders Z if any. In this way, the n subjects are re-
sampled under the null hypothesis of no association.
• Step (2): To estimate the relationship between the outcome and the set of features 
while accounting for possible confounding effects, compute M regression models in 
a univariate approach, that is by using one feature at a time. From each model store 
the p value associated with the feature of interest. When appropriate, approaches 
other than regression methods can be used for testing of association e.g. correlation 
or t-test.
• Step (3): Extract the minimum of the set of M p values as this indicates the highest 
threshold value which would reject all M null hypotheses.
• Step (4): Repeat Step (1)–(3) for K times, where K is at least n/2 times [11]. The K 
minimum p values are the elements of the new vector q.
• Step (5): Sort the elements of q, and take the ( αK )-value of this vector. This value 
is the MWSL estimate. An approximate confidence interval can be obtained by 
treating the true position of the MWSL estimate as a Binomial random variable 
with parameters K and α . Then, using the Normal approximation to the Binomial, 
we obtain the z(1−α)% confidence limits by extracting the elements of q in positions 
(αK )± {(1− α)
√
αK (1− α)}.
• Step (6): Compute the effective number of tests (ENT) defined as the number of 
independent tests that would be required to obtain the same significance level using 
the Bonferroni correction ENT = αMWSL . The ENT estimate measures the extent that 
the M markers are non-redundant. Therefore, the ratio R = ENTM % of the effective 
and the actual number of tests (ANT or M) is a measure of the dependence among 
features, which is expected to be closer to 0% when highly correlated features are 
considered.
Permutation-based procedures have previously been applied in different studies e.g. by 
[12] to approximate the genome-wide significance threshold for dense SNP and rese-
quencing data, or by [13] for urinary metabolic profiles. Recently in the context of NMR 
metabolic profiling studies [14] employed the permutation algorithm to perform a series 
of MWAS for serum levels of glucose. Counterintuitively, ENT estimates greater than 
the ANT were found, with an R ratio for glucose over 400%. With the methodology pro-
posed in this paper, we generalise the algorithm to a more flexible regression context 
compared to [13], while we provide a robust framework to avoid biased estimates as in 
[14].
Parametric simulation methods
The underlying assumption of the permutation procedure is that the p values are prop-
erly calibrated, that is, every metabolite-specific p value is uniformly distributed, i.e. p 
valuem ∼ U(0, 1) where m = 1, . . . ,M , when the null hypothesis is true. Because the 
MWSL is the minimum p value across the metabolite specific tests, all it takes is one 
poorly calibrated test with an erroneous small p value to bias the MWSL estimation. Very 
often in metabolomics studies the features are not normally distributed. Nevertheless, 
normality only matters sometimes. It matters when both the feature and the outcome 
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have a skew distribution [15], while it has very little effect when either the feature or the 
outcome is normally distributed. In this context, we investigate the properties of the per-
mutation approach for significance level estimation by employing the multivariate Nor-
mal and the multivariate log-Normal distributions to describe, at least approximately, 
the set of correlated features and to obtain stable estimates of the MWSL while effec-
tively controlling the maximum overall type I error rate at the α level. We assume that 
the data are already centred so that the means equal zero. Therefore, X ∼ NM(µ,�∗) 
is the multivariate Normal distribution employed to simulate the set of features where 
µ = E[X] = (E[X1], . . . , E[XM])T = 0 is the M-dimensional mean vector of zero means, 
and ∗ is the (M ×M) shrinkage estimator of the covariance matrix as described by [16]. 
The shrinkage estimator is always positive definite, well-conditioned, more efficient and 
therefore preferred to the unbiased estimator  , or to the related maximum likelihood 
estimator ML . Where the probability density of a feature is right skewed, we use the 
multivariate log-Normal approximation. In such cases, the features are first transformed 
i.e. the absolute value of their minimum, plus one unit, is added to their original value. 
The algorithm is applied to real-data and simulated scenarios to illustrate the results for 
different model parametrizations and various type of outcome, as well as to investigate 
different correlation levels across features and between the features and the outcome.
Practical approximation of the ENT
The empirical method of computing the permutation test p value is hampered by the 
fact that a very large number of permutations are required to correctly estimate small, 
and therefore interesting p values. Thus, we now present a more efficient alternative to a 
standard permutation test to derive the MWSL. To distinguish from the effective num-
ber of non-redundant variates from the permutation procedure which has been defined 
as ENT in Section “Methods”, here we refer to the estimate from this practical approxi-
mation approach as Meff. It has previously been shown that the collective correlation 
among a set of variables can be measured by the variance of the eigenvalues (  s) derived 
from a correlation matrix [6, 17]. In particular, high correlation among variables leads to 
high  s, that is, when all variables are completely correlated, the first  equals the num-
ber of variables in the correlation matrix (M) and the rest of the  s are zero. Vice versa 
in the case of no correlation among variables, all the  s will be equal to 1 with zero vari-
ance. Hence, the variance of the  s will range between zero, and M. Based on this con-
cept, within the genomics field several methods have been proposed for estimating the 
ENT from the correlations between variates. Among the first, [7] proposed to use the 
variance of the  s to estimate the ENT for the limiting cases of none/ fully correlated 
variables, and a ratio of the eigenvalue’s variance to its maximum M for intermediate 
situations. [8] suggested summing the  s, after substituting 1 for the  s that are greater 
than 1. [9] suggested defining ENT as the number of  s which can explain a certain 
percentage of the variation within the data. However, it is unclear how the percentage 
should be chosen as an excessively large or small value would result in an FWER that is 
overly conservative or liberal. [10] proposed a measure of ENT based on a  s ratio func-
tion. In the context of our analyses, the Meff measures proposed by these authors were 
not sufficiently accurate as a valid substitute for the permutation procedure, hence we 
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propose an empirical closed-form expression directly related to the correlation among 
metabolomics variates as follows
This formulation balances the information from the m with m = 1, . . . ,M estimated 
eigenvalues from the correlation matrix of the metabolite concentrations, with the con-
tribution of the first eigenvalue 1 which measures the primary cluster in the matrix, its 
number of variables, and the average correlation among the features [18]. This formula-
tion is of interest in the context of correlated variates, that is when at least two variates 
are dependent, i.e. for 1 > 1 , and therefore log(1) > 0.
Next, the MWSL can be derived based on the following.
• Step (1): Compute the MeffMWSL with the proposed formulation.




Alternatively, the full algorithm as an alternative to the permutation procedure can be 
described as follows.
• Step (1): Compute the MeffMWSL with the proposed formulation.
• Step (2): Under the null hypothesis the p value of each metabolite follows a Uniform 
distribution, i.e. p valuem ∼ U(0, 1) , where m = 1, . . . ,M . The distribution of mini-
mum p values can be approximated by the minimum order statistics (r=1), that is 
U(1) ∼ Beta(1, M) in the case of not correlated molecular variates, and Beta(1,M′) 
with M′  M in the case of correlated features. The limit case of very highly cor-
related features with M′ = 1(<< M) reduces to sampling from a Beta(1,  1) which 
equals a U(0, 1). It follows that the MeffMWSL can be used to approximate the distri-
bution of minimum p values by sampling from a Beta(1,MeffMWSL).
• Step (3): The MWSL and its respective z(1−α) % confidence limits can be derived as 
described in Section “Permutation algorithm”, Step (5)–(6) of the permutation proce-
dure.
Results
Study of experimental metabolomics data
The MWAS approach was employed to investigate the association between human 
serum 1 H NMR metabolic profiles and various clinical outcomes in the Multi-Ethnic 
Study of Atherosclerosis (MESA) [19]. The data have been extensively described in [14]. 
Briefly, the cohort includes participants (51% females, 49% males), aged 44-84 years, 
(mean=63 years) from four different ethnic groups: Chinese-American, African-Amer-
ican, Hispanic, and Caucasian, all recruited between 2000 and 2002 at clinical centres 
in the United States and free of symptomatic cardiovascular disease at baseline. Demo-
graphic, medical history, anthropometric, and lifestyle data, as well as serum samples 
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treatment. Metabolic profiles were obtained using 1 H NMR at 600 MHz and processed 
as detailed in [20]. The outcomes of interest are glucose concentrations and the body 
mass index (BMI). Table  1 presents the descriptive statistics for the clinical outcome 
measures, while Table 2 reports the descriptive statistics for the fixed effects covariates 
used in the study. Three sets of NMR spectra are considered: (1) a standard water-sup-
pressed one-dimensional spectrum (NOESY), (2) a Carr-Purcell-Meiboom-Gill spec-
trum (CPMG), and (3) a lower resolution version of the CPMG data (BINNED1). The 
BINNED version consists of M=655 features, while the NOESY and CPMG contain 
M=30,590 features. The BINNED data sample comprises of n=3,500 individuals, while 
the NOESY and CPMG data have n=3,867 individuals. All MWSL calculations are per-
formed for α = 0.05.
From the conventional permutation procedure applied to the BINNED data shown in 
Fig. 1, when the real features are considered, there is instability in the estimation of the 
ENT across the different outcomes, and in particular the ENT estimate for glucose is 
above the ANT. When the data are simulated from a multivariate log-Normal or Normal 
as described in Section “Parametric simulation methods” the ENT estimates are stable 
across the different outcomes and remain bounded below the total number of features 
Table 1 Descriptive statistics for the clinical outcome measures
Outcome Mean sd Median Min Max Skewness Kurtosis
Glucose (mg/dL) 98.28 31.10 90 38 507 4.17 28.89
Logarithm of Glucose 4.56 0.23 4.5 3.64 6.23 2.22 10.35
BMI (kg/m2) 28.14 5.39 27.34 15.36 61.86 46.50 4.45
Logarithm of BMI 3.32 0.18 3.31 2.73 4.12 1.39 3.20
Table 2 Descriptive statistics for the fixed effects covariates
Covariate Mean sd
Age (years) 62.89 10.32
Gender 0.51 0.49
Height (cm) 166.43 10.23
Ethnicity: Caucasian 0.39 0.49
Ethnicity: Hispanic 0.23 0.42
Ethnicity: African-American 0.25 0.43
Ethnicity: Chinese-American 0.13 0.34
Smoking: Never 0.51 0.50
Smoking: Former 0.12 0.33
Smoking: Current 0.38 0.48
LDL cholesterol (mg/dL) 117.67 31.04
HDL cholesterol (mg/dL) 51.29 14.41
Systolic blood pressure (mmHg) 126.92 21.54
Blood pressure treatment 0.38 0.49
Diabetes 0.14 0.34
Lipids treatment 0.17 0.37
1 Binning is a common data reduction approach in NMR metabolomics.
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with an average ENT around 350 and an R ratio around 50%. To assess the validity of this 
result in terms of redundancy of the set of features we considered principal component 
analysis (PCA) as an alternative method for estimating the ENT [6–8]. The cumulative 
proportion of variance explained by the first 350 PCs is around 99%. This is consistent 
with the interpretation that there are effectively 350 uncorrelated features in the data.
Figure  2 reports the ENT estimates for CPMG data. Without any transformations 
applied, there is a very large variation across the ENT estimates for the different out-
comes, and in particular a very high and meaningless estimate for glucose levels which 
goes beyond R = 400%. On the other hand, when the set of features is simulated from 
the multivariate Normal and from the multivariate log-Normal distribution the corre-
sponding ENT estimate is below the total number of features, and stable across different 
outcomes with an average ENT of around 16,000 features and an R ratio around 50%. 
In this case the usefulness of the proposed permutation method to estimate the ENT is 
clear since the PCA-based ENT estimate would be constrained to the maximum number 
of PCs ( n = 3866 i.e. max no. PC is n-1).
Figure 3 reports the ENT estimates for the NOESY data which are below R=100% but 
vary across outcomes when the original set of features is considered. When simulated 
features from the multivariate (log-) Normal distributions are considered we obtain 
lower ENT values than the ones from the CPMG data, with an average ENT of around 
2700 features and an R ratio around 9%. This result was expected due to the reduced 
influence of broad signals in CPMG spectra compared to NOESY, which is linked to a 
weaker covariance structure. By applying a PCA to the NOESY data the cumulative pro-
portion of variance explained by the first 2,700 PCs is around 99%, and this is in line with 
our findings.
Next, by exploiting the approximation method described in Section “Practical approx-
imation of the ENT”, we derive the proposed MeffMWSL . Table 3 provides this estimate 
compared to the available alternative methods proposed by [7–9], and [10], and the ENT 
estimate from the permutation procedure which is the averaged estimate of the results 
obtained via the multivariate and log-multivariate Normal transformations. Considering 
the complexity of the eigenvalue structure in cases of very large data sets, the proposed 
MeffMWSL in most cases seems to be able to consistently quantify, at least approximately, 
Table 3 Real data: Comparison of  estimation of  the  number of  non-redundant variates 
from  the  permutation method (ENT, obtained as  the  average of  the  ENT estimates 
for  all the  clinical outcomes measures considered via  the  multivariate Normal 
and  the  multivariate log-Normal methods) and  via  approximation procedures based 
on the eigenvalues of the correlation matrix of the metabolite concentrations (Meff)
R = ENT/ANT(%) ratio in brackets. ANT = 655 for the MESA BINNED data, and ANT = 30590 for the NOESY and CPMG data. 
Meff estimates closest to ENT estimates in bold
MESA BINNED MESA NOESY MESA CPMG
ENT 352(53.8%) 2744(9.0%) 16014(52.3%)
Meff.MWSL 345(52.7%) 1931(6.3%) 11570(37.8%)
Meff.Galwey [10] 201(30.7%) 524(1.7%) 1815(5.9%)
Meff.Gao [9] 435(66.4%) 2705(8.8%) 3537(11.6%)
Meff.Liji [8] 226(34.5%) 2534(8.3%) 4972(16.3%)
Meff.Nyholt [7] 611(93.3%) 26823(87.7%) 29704(97.1%)
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the correlation structure of the metabolomic variates. Based on this Meff estimate, to 
derive the MWSL and its confidence limits we simulate from a Beta(1,MeffMWSL ) which 
lets us obtain MWSL estimate of the same order of magnitude as those from the permu-
tation procedure as shown in Table 4.
Simulation study
We now broaden the investigation by considering various correlation levels of the set 
of molecular variates as well as cases of correlation between the outcome and the vari-
ates. At first we generate various sets of variates, each of these with a specific and well 
bounded correlation level. This is performed following the algorithm described in Sec-
tion “Parametric algorithm to generate synthetic variates”. Specifically, we generated nine 
sets of variates covering the whole range of positive correlation levels. Next, we generate 
outcomes both correlated and uncorrelated to the variates which we will employ within 
the permutation procedure to estimate the ENT across the various sets of correlated 
molecular variates. Uncorrelated outcomes of different shapes are easily simulated via 
parametric distributions such as the Normal distribution for a symmetric outcome, the 
Skew-Normal distribution for a left skewed outcome, and a Weibull distribution for a 
right skewed outcome. Figure 4 shows the ENT estimates in the case of correlated vari-
ates and uncorrelated outcomes. Simulated correlated outcomes can be obtained as a 
linear combination of a few randomly chosen molecular variates with added noise, or 
via procedures based on Cholesky decomposition as is performed when simulating cor-
related features following the algorithm detailed in Section  “Parametric algorithm to 
generate synthetic variates”. Figure  5 show the ENT estimates from the permutation 
procedure for the various sets of synthetic molecular variates and the correlated simu-
lated outcomes. We conclude that correlation to the outcome makes no discernible dif-
ference to relationships between ENT and variate-variate correlation. Lastly, we apply 
the MeffMWSL approximation to derive the results in Tables 5 and 6. The ENT from the 
permutation procedure is averaged from the results in Figs. 4 and  5. In this simulated 
Table 4 Real data: MWSL estimation comparison between  the  permutation method 
and  the  approximation procedure generating the  distribution of  the  minimum p value 
as a Beta(1,MeffMWSL)
MESA BINNED MESA NOESY MESA CPMG
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environment, the MeffMWSL approximation outperforms other available methods and 
describes well the permutation-based ENT estimates.
Validation of the approach
A type I error (false-positive) occurs when a true null hypothesis is rejected. To check 
whether the permutation procedure accounts for the FWER at the α level, for each met-
abolic variate and across the permutation replicates, we measure the type I error rate as 
the number of occurrences having a p value less or equal to the MWSL. Rather than the 
Table 6 Simulated data: MWSL estimation comparison between the permutation method 
and  the  approximation procedure generating the  distribution of  the  minimum p value 
as a Beta(1,  MeffMWSL)
Correlation ∈ [0.95-1) Correlation ∈ [0.65,0.75) Correlation ∈ [0.35,0.45)
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original real-data outcomes we test the multivariate (log-)Normal permutation proce-
dure to calculate the MWSL using various synthetic outcomes. In particular, we employ 
Fig. 1 BINNED data: ENT across clinical outcome measures and for different approximations of the variates: 
original data, multivariate Normal, multivariate log-Normal. Error bars represent 95% confidence limits. 
K=10,000 permutations
Fig. 2 CPMG data: ENT across clinical outcome measures and for different approximations of the variates: 
original data, multivariate Normal, multivariate log-Normal. Error bars represent 95% confidence limits. 
K=10,000 permutations
Fig. 3 NOESY data: ENT across clinical outcome measures and for different approximations of the variates: 
original data, multivariate Normal, multivariate log-Normal. Error bars represent 95% confidence limits. 
K=10,000 permutations
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a continuous outcome from a Normal distribution, a discrete-binary outcome from a 
Binomial distribution, a discrete-count outcome from a Poisson distribution, and a 
time-to-event survival outcome from the Cox proportional hazards model as in [21]. We 
benchmark our result on the MESA BINNED data but also on a set of synthetic variates 
obtained via a nonparametric approach using PCA (see Section 6.2). We divide the data 
into test and non-test sets, compute a PCA model of the non-test data, and predict the 
test data based on this model. This approach allows us to generate synthetic data based 
on the structure of the real data without involving bootstrap/permutation methods [22] 
which we already employ to estimate the MWSL. Following the algorithm of Section 7.2 
applied to the MESA BINNED data, we define the test and the nontest set by randomly 
sampling nt = 1, 500 and nt̄ = 3500− 1500 = 2, 000 observations, respectively. From 
the PCA on the nontest set we select 350 PCs to be used to build the simulated test set of 
Fig. 4 ENT for uncorrelated outcomes across correlated variates. Error bars represent 95% confidence limits. 
K=5,000 permutations
Fig. 5 ENT for correlated outcome across correlated variates. Error bars represent 95% confidence limits. 
K=5,000 permutations
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molecular variates X̂t . Table 7 and Table 8 confirm that the MWSL procedure effectively 
controls the FWER close to the (default) α-level of 5%.
Conclusions
In this paper we focus on assessing univariate test significance in multi collinear omics 
data by estimating a significance level threshold controlling the family wise error rate. 
The proposed procedure is based on an iterative permutation approach via univariate 
regression models while other measures of association may be used when appropriate. 
The molecular variates are simulated via parametric methods such as multivariate Nor-
mal and multivariate log-Normal distributions to retain the correlation structure in the 
data, while controlling the false positive rate at the desired level. When the permuta-
tion procedure is applied to the approximated data the MWSL is stable across outcome 
measures with diverse properties.
In MWAS, the metabolic profiles often exhibit a high degree of collinearity, and this 
is supported by our finding that in all scenarios considered, when parametric methods 
are applied to approximate the structure of the data, the MWSL estimated through 
the permutation procedure is larger than the threshold obtained via a metabolome-
wide Bonferroni or Sidak corrections. Therefore, the corresponding ENT is always 
less than the actual number of tests as it mainly depends on the extent of correlation 
within the data. The extent of collinearity is summarized by the R ratio (%) of effective 
to actual number of tests. For the examples in this paper, R was found to be around 
50% for the CPMG data (high-resolution and BINNED version), and around 9% for 
the NOESY high resolution. This is consistent with the expected higher degree of cor-
relations between spectral variables in the NOESY data. As with other approaches, 
the proposed closed-form Meff approximation to the permutation-based ENT could 
be tentatively interpreted as the number of independent metabolic processes exhib-
ited by the system. Both the MWSL or the Meff estimate can be employed down-
stream of the analysis to identify differentially regulated metabolites.
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Appendix
Parametric algorithm to generate synthetic variates
• Step (1): Generate a square (M ×M) correlation matrix A assuming all variables have 
unit variance, i.e. the M elements on the diagonal are 1s. The [M(M − 1)]/2 elements 
of the upper triangular matrix are sampled from Uniform distributions bounded by a 
certain interval, e.g. high correlation level within the interval [0.75,0.85], medium cor-
relation in [0.45,0.55], or low correlations in [0.25,0.35]. The lower triangle elements are 
copied from the upper triangle.
• Step (2): As the  s of A are required to be greater than zero, com-
pute S as the nearest positive definite to the correlation matrix A achieving 




ij as described by 
[23].
• Step (3): Derive the lower triangular matrix L via Cholesky decomposition of matrix S 
such that S = LL’.
• Step (4): M multivariate Normal features with zero means result from the product ZL 
between the (n×M) matrix Z of M random N(0,1) i.i.d. features, and the (M ×M) 
lower triangular matrix L. The correlations of the simulated features are very close to 
those assigned in matrix A.
Nonparametric algorithm to generate synthetic variates
• Step (1): By randomly sampling nt observations from the original data matrix of vari-
ates X, construct the (nt ×M) test set of variates Xt , and the (nt̄ ×M) nontest set Xt̄ , 
with nt < n and nt̄ = n− nt.
• Step (2): Standardise the test and the nontest sets by subtracting their respective vec-
tors of column means i.e. µt and µt̄ , and dividing by their standard deviations i.e. σt 
and σt̄ , to respectively obtain Zt and Zt̄.
• Step (3): Compute PCA over the nontest set by applying singular value decomposi-
tion (SVD) such that Zt̄ = Ut̄t̄V Tt̄  , where V
T
t̄
 is the (M ×M) matrix of loadings, 
while the PC scores are obtained as the product between the (nt̄ × nt̄) matrix Ut̄ of 
eigenvectors of Zt̄ZTt̄  , and the (nt̄ ×M) diagonal matrix t̄.
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• Step (4): Use the nontest loadings Vt̄ combined with the test Xt to compute the 
(nt ×M) matrix Ût̂t of PC predicted scores for the test set, i.e. Ût̂t = XtVt̄.
• Step (5): Build the (nt ×M) simulated test set of variates Ẑt as the product of the 
predicted scores from Step (4), and the matrix of loadings VT
t̄
 from Step (3) such that 
Ẑt = Ût̂tV Tt̄  . We note that S PCs, with S ≤ M , can be selected to be used in the 
predictions, thus Ẑt would result from the product of the (nt × S) matrix of PCs and 
the (S ×M) matrix of loadings.
• Step (6): From the simulated test set of standardised features Ẑt compute the 
(M ×M) set of simulated features as X̂t = Ẑtσt + µt.
To simulate the set of variates in such way the sample size of the data should be large 
enough for the data to be split between the test and the nontest set, and no missing val-
ues are allowed. Nevertheless, a possible extension of this method would consider the 
Nonlinear Iterative Partial Least Squares (NIPALS) algorithm as a modified PCA to 
accommodate missing values [24].
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